Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: pathology

Laboratories Sit Squarely Between New Genetics and Today’s Medicine

The Dark Report / By Robert Michel

“Clinical laboratories and pathology groups are at the leading edge of the genetic revolution.” —Rick J. Carlson. CEO SUMMARY: Healthcare futurist Rick J. Carlson believes that knowledge of the human genome will trigger revolutionary changes in the American healthcare system. In particular, Carlson predicts consumers will drive the primary shift in the way healthcare services …

Laboratories Sit Squarely Between New Genetics and Today’s Medicine Read More »

To access this post, you must purchase The Dark Report.

Several Major Surprises Mark Events of 2002

The Dark Report / By Robert Michel

CEO SUMMARY: It was a year when the two blood brothers got much bigger and expanded market share by buying their largest competitors. With patient safety as the goal, employers began active steps to force hospitals, physicians, and other healthcare providers to use quality management systems to reduce errors. Unpredictable in many ways, 2002 set …

Several Major Surprises Mark Events of 2002 Read More »

To access this post, you must purchase The Dark Report.

More Consolidation: Where Will It Lead?

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

I CERTAINLY DID NOT FORESEE ALL THE LAB ACQUISITION ACTIVITY that occurred during 2002. Compared to recent years, both Quest Diagnostics Incorporated and Laboratory Corporation of America have been on a buying spree this year. Quest Diagnostics acquired American Medical Laboratories in April and has an agreement to acquire Unilab Corporation, pending a decision by …

More Consolidation: Where Will It Lead? Read More »

To access this post, you must purchase The Dark Report.

Another Lab Acquisition: LabCorp To Buy DIANON

The Dark Report / By Robert Michel

CEO SUMMARY: Laboratory Corporation of America Holdings will pay almost $598 million to buy DIANON Systems, Inc. of Stratford, Connecticut. With this move, anatomic pathology becomes a high profile growth target for LabCorp. During the past eight years, DIANON Systems has built a national business providing highly specialized anatomic pathology and esoteric testing services to …

Another Lab Acquisition: LabCorp To Buy DIANON Read More »

To access this post, you must purchase The Dark Report.

Why DIANON Sale Alters Anatomic Path Market

The Dark Report / By Robert Michel

CEO SUMMARY: By acquiring DIANON Systems, LabCorp raises the level of competition for tissue specimens originating in physicians’ offices. LabCorp’s acquisition is also a validation of predictions that cancer diagnostics will be a high-growth segment of laboratory medicine. Anatomic pathologists have ample warning that new national competitors will soon attempt to capture local physician accounts. …

Why DIANON Sale Alters Anatomic Path Market Read More »

To access this post, you must purchase The Dark Report.

“Direct-to-Consumer” Ad Runs in New York Times

The Dark Report / By Robert Michel

CEO SUMMARY: Two pioneering advertising campaigns launched in September. Both Myriad Genetics and IMPATH targeted consumers with advertisements about diagnostic testing. In each case, the most vocal response to the advertising came from within the medical community. Within the pathology profession, IMPATH’s full-page advertisement in the New York Times Sunday Magazine was not well-received by …

“Direct-to-Consumer” Ad Runs in New York Times Read More »

To access this post, you must purchase The Dark Report.

Disease Management Relies On Lab Testing

The Dark Report / By Robert Michel

CEO SUMMARY: Predictions are that 30% of large corporations will offer disease management programs for their employees by the end of next year. Disease management seems to be the next form of managed care, where prevention and early detection are the primary goals. Laboratories should be alert for opportunities to add value to these programs. …

Disease Management Relies On Lab Testing Read More »

To access this post, you must purchase The Dark Report.

San Fran Bay Hospitals Jointly Fund MT Training

The Dark Report / By Robert Michel

CEO SUMMARY: Laboratory administrators in 15 Bay-area hospitals created their own plan to expand the available pool of trained med techs. Using a detailed analysis of the demographics of the problem, along with a financial analysis of non-action, they convinced CEOs of 15 hospitals to invest $1.5 million in a five-year training program. EDITOR’S NOTE: …

San Fran Bay Hospitals Jointly Fund MT Training Read More »

To access this post, you must purchase The Dark Report.

ARUP & Mayo Respond To New Market Cycle

The Dark Report / By Robert Michel

CEO SUMMARY: Since the beginning of 2002, several important events changed the competitive status quo among the nation’s leading providers of hospital send-out testing. As part of its ongoing assessment of this market segment, THE DARK REPORT provides strategic management insights from executives at ARUP Laboratories and Mayo Medical Laboratories. IN THE HOSPITAL SEND-OUT marketplace, …

ARUP & Mayo Respond To New Market Cycle Read More »

To access this post, you must purchase The Dark Report.

Non-Pathologists Altering U.S. Laboratory Industry

The Dark Report / By Robert Michel

CEO SUMMARY: It’s an interesting contradiction. On one hand, most pathologists enthusiastically recognize the value that diagnostic testing services provide to the healthcare community. On the other hand, too often it is non-laboratorians who provide the investment capital and entrepreneurial effort required to build the laboratory organization capable of delivering these diagnostic services. IS THE …

Non-Pathologists Altering U.S. Laboratory Industry Read More »

To access this post, you must purchase The Dark Report.

;